HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dial settlement

This article was originally published in The Rose Sheet

Executive Summary

Personal care marketer settles sexual harassment lawsuit with U.S. Equal Employment Opportunity Commission for $10 mil. April 29 in last minute negotiations before the start of the trial, the two parties announce. In addition to monetary relief, Dial also agreed to revise existing policies and procedures that prohibit sexual harassment and will use a third party to resolve future disagreements. Lawsuit filed by EEOC in 1999 alleged 90 female workers at Dial's Aurora, Ill. manufacturing facility were subjected to verbal abuse, pornography and assault. EEOC had predicted Dial's liability in the case could exceed $25 mil. (1"The Rose Sheet" Aug. 27, 2001, In Brief). Dial maintains it "does not tolerate harassment of any kind" and is committed to the "moral and business importance of providing equal opportunity and a positive work environment for all employees"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel